Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

India Diabetes Market Analysis

The diabetes incidence rate in India stands at around 10.1 crores in 2023. The India diabetes market value is driven by the rising awareness among the patients about the symptoms of diabetes, and its ill effects on health, which has majorly intensified the diagnosis and increased the drug treatment rates in the country.

 

Rapid urbanization and developing healthcare infrastructure are also aiding the industry growth of diabetes in India. In addition to this, extending pharmaceutical contract manufacturing, low-cost drug production, and the introduction of advanced technologies have further accelerated the growth of diabetes market in India. In July 2023, the Indian Institute of Technology (IIT) Bhilai and Shiv Nadar University revealed “smart insulin”, which contains an extended period of insulin release that lasts up to 2 days, far greater than the average 12-hour duration of regular insulin.

 

To meet the high India diabetes market demand, leading health platforms for diabetes like the BeatO App have announced their physical clinic collaborations. After launching 5 clinics across Delhi-NCR, the company visions to spread across Uttar Pradesh, Madhya Pradesh, Rajasthan, Gujarat, and Odisha in the next 6 months. Akums Drugs and Pharmaceuticals Limited also received approval for its triple combination diabetes treatment which includes Sitagliptin 100, Pioglitazone 15 and Metformin 1000/500. Therefore, the market is expected to witness significant growth in the forecast period.

 

India Diabetes Market Report Snapshots

India Diabetes Market Size

India Diabetes Market Analysis

India Diabetes Treatment Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about INR 316 billion in 2023, driven by rising incidence of diabetes cases in the region.

The market is anticipated to grow at a CAGR of 16% during the forecast period of 2024-2032, likely to reach a market value of INR 1201.74 billion by 2032.

The market demand is driven by increasing government and private institution driven awareness initiatives among the patients about the symptoms and treatment of diabetes.

The current market trend is driven by the advent of new technical inventions. In July 2023, IIT Bhilai and Shiv Nadar University collaborated to develop a “smart insulin”.

Diabetes can be divided into type 1 diabetes and type 2 diabetes.

Treatment types include insulin-based and non-insulin-based, among others.

Dose forms include tablets and capsules, injections, creams and gels, among others.

Major distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and others.

Major end users include hospitals, speciality clinics, and homecare settings, among others.

The route of administration can be oral or parenteral.

Key players involved in the market are Sun Pharmaceutical Industries Ltd., Biocon Limited, Dr. Reddy's Laboratories Ltd., Novo Nordisk India Pvt. Ltd., Sanofi India Limited, Eli Lilly and Company (India) Pvt. Ltd., Johnson & Johnson Private Limited, Abbott India Limited, Glenmark Pharmaceuticals Ltd., AstraZeneca Pharma India Limited, Lupin Limited, Torrent Pharmaceuticals Ltd., Merck Limited, Cadila Healthcare Limited and Wockhardt Limited.

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,869

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,799

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear=calculateFutureValue(($getReportDetail['base_value']> 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>